Primary progressive


Also found in: Acronyms.

Primary progressive

A pattern of symptoms of multiple sclerosis in which the disease progresses without remission, or with occasional plateaus or slight improvements.
Mentioned in: Multiple Sclerosis
References in periodicals archive ?
Pharmascroll has generated over 30 market research reports in multiple disease indications including Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis and Migraine disease indications in less than a year of the launch of company.
Rocheannounced today that the European Commission (EC) has granted marketing authorisation for OCREVUS (ocrelizumab) for patients with active relapsing forms of multiple sclerosis defined by clinical or imaging features and for patients with early primary progressive multiple sclerosis in terms of disease duration and level of disability, and with imaging features characteristic of inflammatory activity.
The drug has been indicated for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis, a form of the neurological disease that until now was without an approved medicine.
As of 1 December 2017, the ARPEGGIO study, with laquinimod in primary progressive MS (PPMS) sponsored by Teva, was reported not to achieve its primary end point.
USPRwire, Thu Nov 02 2017] This report provides top line data relating to the clinical trials on Primary Progressive Multiple Sclerosis (PPMS).
Andy Clarke, from Burntwood, provided wife Vicky with cannabis after she was diagnosed with primary progressive multiple sclerosis which caused stabbing pains in her left shoulder.
The open-label, single-arm study is expected to enroll a total of 60 patients: 30 patients with progressive forms of MS, either primary progressive MS or secondary progressive MS, and 30 patients with relapsing-remitting MS across Australia, the US, and Europe.
National Institute of Neurological Disorders and Stroke (NINDS) Santhera is developing Raxone in a third indication, primary progressive multiple sclerosis (PPMS), and omigapil for congenital muscular dystrophy (CMD), all areas of high unmet medical need.
Food and Drug Administration (FDA) approved Roche's multiple sclerosis (MS) drug Ocrevus (ocrelizumab) last March to treat adult patients with relapsing forms of MS and primary progressive multiple sclerosis (PPMS), marking the first drug approved by the FDA for PPMS.
Her condition, primary progressive MS, caused a rapid deterioration of the myelin sheath and led to her condition worsening very quickly.
Colwyn Bay-born Jones is suffering from primary progressive aphasia, which is a form of dementia that affects his ability to communicate.

Full browser ?